Physical and chemical characterization insulin-loaded chitosan-TPP nanoparticles

被引：66

作者：

Azevedo, J. R. ^{[1
]}

Sizilio, R. H. ^{[1
]}

Brito, M. B. ^{[1
]}

Costa, A. M. B. ^{[1
]}

Serafini, M. R. ^{[1
]}

Araujo, A. A. S. ^{[1
]}

Santos, M. R. V. ^{[1
]}

Lira, A. A. M. ^{[1
]}

Nunes, R. S. ^{[1
]}

机构：

[1] Univ Fed Sergipe, Dept Fisiol, BR-49100000 Sao Cristovao, Sergipe, Brazil

来源：

JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY | 2011年 / 106卷 / 03期

关键词：

Nanoparticles; Chitosan; Insulin; Thermal analysis; FTIR; ABSORPTION; POLYSACCHARIDE; STABILITY; PROTEINS;

D O I：

10.1007/s10973-011-1429-5

中图分类号：

O414.1 [热力学];

学科分类号：

摘要：

The purpose of this study was to develop and characterize insulin nanoparticles systems using chitosan. Insulin-loaded nanoparticles were prepared by ionic gelation of chitosan with tripolyphosphate anions (TPP). The interactions between insulin and chitosan were evaluated by differential scanning calorimetry (DSC), thermogravimetry/derivative thermogravimetry (TG/DTG), and Fourier-transform infrared (FTIR) spectroscopy. Besides, particle size distribution, polydispersity index (PDI), zeta potential, and association efficiency (AE%) of the nanoparticles were evaluated. In general, inert nanoparticles and insulin-loaded nanoparticles showed an average size of 260.56 nm (PDI 0.502) and 312.80 nm (PDI 0.481), respectively. Both nanoparticles showed positive charge, but after insulin incorporation the zeta potential was reduced, evidencing its incorporation. Nanoparticles obtained also showed AE% around 70%, measured by high-performance liquid chromatography (HPLC). The results of FTIR, DSC, and TG/DTG corroborated the data presented suggesting that insulin was successfully encapsulated. However, drug incorporation seems to be related not only to electrostatic interactions, but also to physical process and/or adsorption phenomena.

引用

页码：685 / 689

页数：5

共 25 条

[1] Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats [J].

Barichello, JM ;

Morishita, M ;

Takayama, K ;

Nagai, T .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (02) :189-198

[2] Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: Ex vivo and in vivo studies [J].

Bayat, Akbar ;

Dorkoosh, Farid A. ;

Dehpour, Ahmad Reza ;

Moezi, Leila ;

Larijani, Bagher ;

Junginger, Hans E. ;

Rafiee-Tehrani, Morteza .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 356 (1-2) :259-266

[3] Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note [J].

Bhumkar, Devika R. ;

Pokharkar, Varsha B. .

AAPS PHARMSCITECH, 2006, 7 (02)

[4] Chitosan drug binding by ionic interaction [J].

Boonsongrit, Y ;

Mitrevej, A ;

Mueller, BW .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 62 (03) :267-274

[5] Characterization of drug-chitosan interaction by 1H NMR, FTIR and isothermal titration calorimetry [J].

Boonsongrit, Yaowalak ;

Mueller, Bernd W. ;

Mitrevej, Ampol .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 69 (01) :388-395

[6] Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines [J].

Calvo, P ;

RemunanLopez, C ;

VilaJato, JL ;

Alonso, MJ .

PHARMACEUTICAL RESEARCH, 1997, 14 (10) :1431-1436

[7] Enhancement of nasal absorption of insulin using chitosan nanoparticles [J].

Fernández-Urrusuno, R ;

Calvo, P ;

Remuñán-López, C ;

Vila-Jato, JL ;

Alonso, MJ .

PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1576-1581

[8] Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery [J].

Gan, Q ;

Wang, T ;

Cochrane, C ;

McCarron, P .

COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 44 (2-3) :65-73

[9] Chitosan nanoparticles as delivery systems for doxorubicin [J].

Janes, KA ;

Fresneau, MP ;

Marazuela, A ;

Fabra, A ;

Alonso, MJ .

JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :255-267

[10] Preparation and characterization of chitosan microparticles intended for controlled drug delivery [J].

Ko, JA ;

Park, HJ ;

Hwang, SJ ;

Park, JB ;

Lee, JS .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :165-174

← 1 2 3 →